Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

Mesothelioma Patients Who Use Chemotherapy Booster Live Longer

When you’ve been diagnosed with malignant mesothelioma, you measure your life in weeks and months rather than in years. The rare and fatal form of cancer advances very quickly after it is diagnosed, claiming the lives of its victims within two years of the time that it is identified. Researchers are working hard to find a cure, and at this point in time, the greatest success has been a combination of surgery, radiation therapy and chemotherapy. That approach has been able to offer patients a small extension on the time they have available, but a recent study has shown that patient survival time can be extended even further through the use of a new medication that improves the effectiveness of the standard mesothelioma chemotherapy treatment.

The study was sponsored by drug maker Boehringer Ingelheim. It followed 87 mesothelioma patients who had not previously received any form of chemotherapy and who were judged to be in reasonably good physical condition, without major health concerns.  The patients were given a combination of pemetrexed and cisplatin – the only chemotherapy treatment known to work on mesothelioma – with some also being given an additional dose of a booster drug known as nintedanib. Nintedanib is generally used to treat idiopathic pulmonary fibrosis, and has also been found to be helpful in treating non-small cell lung cancer.

The initial results of the study showed that patients who had been given the nintedanib gained significant amounts of time added to their initial prognosis. According to one of the study’s authors, Federica Grosso, “Benefit was evident in epithelioid histology, with a median overall survival gain of 5.4 months and median progression free survival gain of 4 months.” Though a small percentage of the patients did experience side effects that were severe enough to force them to drop out of the study, the number of patients who dropped out due to reported side effects from a placebo was even higher. The researchers will continue their evaluation of nintedanib, extending the pool of patients to include 450 people diagnosed with mesothelioma.

If you or someone you love has been diagnosed with mesothelioma, its important to keep up to date on the latest research. The Patient Advocates at Mesothelioma. net are dedicated to providing you with current information and the resources you need to make sure that you are getting the best care. Call us today at  1-800-692-8608.

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor and proofreader. She graduated from the College of William and Mary with a degree in English. Her dreams of a writing career were diverted by a need to pay her bills. She spent a few years providing copy for a major retailer, then landed a lucrative career in advertising sales. With college bills for all three of her kids paid, she left corporate America for a return to her original goal of writing. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.

Get Your FREE Resources Sent Overnight

  • New treatment options
  • Veterans benefits & claims
  • $30 Billion asbestos trust fund information
– Or Call – 1-800-692-8608

Site Navigation

Where can I

Get Additional Help?

For over 15 years, we’ve provided the best FREE resources to mesothelioma patients and loved ones. Our resources include information on the leading treatment options and best doctors in your area; lessons learned from survivors; claims and benefits specifically for Veterans; and how to access your share of billions of dollars in trust fund money.

Get Your FREE Resources Sent Overnight

  • New Treatment Options
  • Veteran's Benefits & Claims
  • $30 Billion Asbestos Trust Fund Information
– Or Call – 1-800-692-8608

We are here to help you


If you've been diagnosed with asbestos-related cancer, contact us at 1-800-692-8608 to find out if you are eligible to receive compensation. You can also fill out the form above to receive FREE information.